Büttner, T.; Dietrich, D.; Zarbl, R.; Klümper, N.; Ellinger, J.; Krausewitz, P.; Ritter, M.
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach. Cancers 2024, 16, 482.
https://doi.org/10.3390/cancers16030482
AMA Style
Büttner T, Dietrich D, Zarbl R, Klümper N, Ellinger J, Krausewitz P, Ritter M.
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach. Cancers. 2024; 16(3):482.
https://doi.org/10.3390/cancers16030482
Chicago/Turabian Style
Büttner, Thomas, Dimo Dietrich, Romina Zarbl, Niklas Klümper, Jörg Ellinger, Philipp Krausewitz, and Manuel Ritter.
2024. "Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach" Cancers 16, no. 3: 482.
https://doi.org/10.3390/cancers16030482
APA Style
Büttner, T., Dietrich, D., Zarbl, R., Klümper, N., Ellinger, J., Krausewitz, P., & Ritter, M.
(2024). Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach. Cancers, 16(3), 482.
https://doi.org/10.3390/cancers16030482
